Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment

por Hagbi-Levi, Shira, Abraham, Michal, Tiosano, Liran, Rinsky, Batya, Grunin, Michelle, Eizenberg, Orly, Peled, Amnon, Chowers, Itay
Publicado 2019

Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation

por Abraham, Michal, Wald, Hanna, Vaizel-Ohayon, Dalit, Grabovsky, Valentin, Oren, Zohar, Karni, Arnon, Weiss, Lola, Galun, Eithan, Peled, Amnon, Eizenberg, Orly
Publicado 2017